NIH Grants for Pharmacogenomics Research FY'06 Mar. 12 — April 9* |
||||
City, State, or Country Name
|
Organization Name
|
Principal Investigator
|
Award
|
Title
|
California Portola Valley |
Gene Security Network | Rabinowitz, Matthew | $218,859 | Integrating, Validating & Applying Pharmacogenetic Data |
San Francisco | University of California San Francisco |
Hamilton, Steven P |
$1,764,980 | Pharmacogenomics of Antidepressant Response |
Mountain View | Perlegen Sciences | Stokowski, Renee P | $1,144,992 | Signature SNPs to distinguish Yersinia pestis strains |
La Jolla | University of California San Diego |
Nigam, Sanjay K |
$339,181 | SNPs in Handling of Small Pox Antivirals & Other Drugs |
University of California San Diego |
Yuan, Jason Xj |
$150,788 | SNPs in Idiopathic Pulmonary Artierial Hypertension | |
Florida Tampa |
H. Lee Moffitt Cancer Center | Bepler, Gerold |
$286,873 | Pharmacogenomics of Neoadjuvant Gemcitabine-Pemetrexed |
Edgerton, Mary E |
$217,802 | Clinical & Microarray Data Predict Lung Cancer Outcomes | ||
Massachusetts Boston |
Dana-Farber Cancer Institute | Johnson, Bruce E |
$289,347 | EGFR Mutations in non-Small Cell Lung Cancer |
Meyerson, Matthew L | $325,631 | Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma | ||
Tufts University | Greenblatt, David J | $232,163 | CYP3A Function in Aging African Americans | |
Michigan Ann Arbor |
University of Michigan at Ann Arbor |
Waskell, Lucy A |
$296,151 | Participation of Cytochrome b5 in Anesthetic Metabolism |
New Hampshire Hanover |
Dartmouth College | Hwa, John | $312,285 | Pharmacogenetics of the human prostacyclin receptor. |
Pennsylvania Philadelphia |
Wistar Institute | Showe, Louise C |
$311,770 | Microarray Analysis of Responsiveness of CTCL IL-12 |
Tennessee Memphis |
St. Jude's Children's Research Hospital | Schuetz, Erin G |
$286,300 | PXR: Regulation and Pharmacogenomics |
Texas Houston |
University of Texas MD Anderson Cancer Center | Cinciripini, Paul M |
$531,714 | Pharmacogenetics, Emotional Reactivity & Smoking |
The Woodlands | Molecular Logix | Pienkos, Philip T |
$401,535 | Creating Clinically Relevant EGFR Antagonists |
Virginia Richmond |
Virginia Commonwealth University | Manjili, Masoud H |
$229,888 | Enhancement of HER-2/neu-based therapy using HSP11 |
Washington Pullman |
Washington State University | Jones, Jeffrey P |
$270,730 | Cytochrome P450 Models for Risk Assessment |
Seattle | University of Washington | Rettie, Allan E |
$327,944 | Pharmacogenetics of ADRs: Warfarin Toxicity |
Fred Hutchinson Cancer Research Center | Potter, John D |
$842,309 | Aspirin, UGT1A6 Genotype, and Colon Gene Expression | |
Wisconsin Milwaukee |
Medical College of Wisconsin | Stephens, Michael C | $126,900 | ABC Transporter Pharmacogenetics: Impact on Thiopurine Therapy |
*SOURCE: US National Institutes of Health
|
NIH Grants for Pharmacogenomics Research FY 06 Mar. 12 -- April 9*
Premium